12544797 · Active · incorporated 6 years, 5 months ago · Cambridge
Biotech Biotech & Life Sciences Deep Tech Drug Discovery Series B+
Dunad Therapeutics is a biotechnology company focused on developing new medicines for neurodegenerative diseases using targeted protein degradation therapies.
Dunad Therapeutics Ltd. is a private limited company registered at Companies House under number 12544797, incorporated on 2 April 2020, with a registered office in Cambridge. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 104 filings for this company, including 6 funding rounds. Its most recent round closed in July 2026, raising £438k.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 6 | Jul 2026 | £438k | £0.05 |
| Round 5 | Aug 2024 | £10.1m | £0.23 |
| Round 4 | Jul 2022 | £12.1m | £12.50 |
| Round 3 | Oct 2021 | £9.5m | £12.50 |
| Round 2 | Nov 2020 | £2m | £5.00 |
| Round 1 | Apr 2020 | £3m | £5.00 |
Showing the 10 most recent of 104 filings.
See the complete cap table with every shareholder, founder tags, dilution across 27 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.